Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Disseminated strongyloidiasis].

J P Nozais1, M Thellier, A Datry

  • 1Service de Parasitologie et Mycologie, CHU Pitié Salpêtrière, Paris.

Presse Medicale (Paris, France : 1983)
|June 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy outcomes in women with imported malaria in mainland France: A retrospective study from 2004 to 2014.

Travel medicine and infectious disease·2024
Same author

Erratum to "Management and prevention of imported malaria in children. Update of the French guidelines" [Med Mal Infect 50 (2020) 127-140].

Medecine et maladies infectieuses·2020
Same author

Changes in malaria epidemiology in France and worldwide, 2000-2015.

Medecine et maladies infectieuses·2019
Same author

Bulletin de la Societe de pathologie exotique (1990)·2019
Same author

Management and prevention of imported malaria in children. Update of the French guidelines.

Medecine et maladies infectieuses·2019
Same author

Past, present and future challenges in health care priority setting.

Journal of health organization and management·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Strongyloidiasis, a parasitic infection, can persist through autoinfection and become severe in immunocompromised individuals. Early diagnosis and treatment with ivermectin are crucial due to high fatality rates in disseminated cases.

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Tropical Medicine

Background:

  • Strongyloidiasis is an intestinal parasitic infection prevalent in tropical and subtropical zones.
  • The unique autoinfection cycle allows for persistent infection without re-exposure.
  • Immunocompromised patients, especially those on corticotherapy, are at risk for hyperinfection and disseminated disease.

Purpose of the Study:

  • To highlight the risks associated with Strongyloidiasis, particularly hyperinfection and disseminated forms.
  • To emphasize the critical need for timely diagnosis and treatment in at-risk populations.
  • To inform about current treatment recommendations for disseminated strongyloidiasis.

Main Methods:

  • Review of Strongyloidiasis pathogenesis, focusing on autoinfection and hyperinfection.

Related Experiment Videos

  • Characterization of disseminated strongyloidiasis clinical manifestations.
  • Evaluation of treatment strategies, including ivermectin efficacy.
  • Main Results:

    • Disseminated strongyloidiasis presents with severe gastrointestinal, respiratory, and systemic involvement, including meningitis and bacteremia.
    • The condition has a high fatality rate, estimated at 80% in disseminated cases.
    • Ivermectin is recognized as an effective and well-tolerated treatment option.

    Conclusions:

    • Prompt diagnosis and treatment of Strongyloidiasis are imperative, especially before initiating long-term corticotherapy in susceptible individuals.
    • Understanding the autoinfection cycle is key to managing endemic infections.
    • Ivermectin is the recommended treatment for disseminated strongyloidiasis due to its effectiveness and tolerability.